Next Article in Journal
Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study
Next Article in Special Issue
Connexin-43 in Cancer: Above and Beyond Gap Junctions!
Previous Article in Journal
New Screening Methods in Melanoma
Previous Article in Special Issue
Bayesan Model to Predict R Status After Neoadjuvant Therapy in Pancreatic Cancer
 
 
Review

Article Versions Notes

Cancers 2024, 16(24), 4187; https://doi.org/10.3390/cancers16244187
Action Date Notes Link
article xml file uploaded 16 December 2024 13:18 CET Original file -
article xml uploaded. 16 December 2024 13:18 CET Update -
article pdf uploaded. 16 December 2024 13:18 CET Version of Record https://www.mdpi.com/2072-6694/16/24/4187/pdf-vor
article html file updated 16 December 2024 13:19 CET Original file -
article xml file uploaded 17 December 2024 09:45 CET Update -
article xml uploaded. 17 December 2024 09:45 CET Update -
article pdf uploaded. 17 December 2024 09:45 CET Updated version of record https://www.mdpi.com/2072-6694/16/24/4187/pdf-vor
article html file updated 17 December 2024 09:46 CET Update -
article xml file uploaded 18 December 2024 05:23 CET Update -
article xml uploaded. 18 December 2024 05:23 CET Update https://www.mdpi.com/2072-6694/16/24/4187/xml
article pdf uploaded. 18 December 2024 05:23 CET Updated version of record https://www.mdpi.com/2072-6694/16/24/4187/pdf
article html file updated 18 December 2024 05:25 CET Update https://www.mdpi.com/2072-6694/16/24/4187/html
Back to TopTop